NCT00294515 · Interventional trial
IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients
Overall registry status Completed
Phase 3
Conditions Cytomegalovirus Infections
Delaware Valley sites
- Hahnemann Uni Hospital; Division of Transplant/Dept. of Surgery · Philadelphia, PA · Philadelphia County
- Uni of Pennslyvania Medical Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory